<DOC>
	<DOCNO>NCT00870272</DOCNO>
	<brief_summary>This open-label , randomize study conduct determine whether dose 400 mcg buccal misoprostol ( i.e. , cheek ) take 24 hour follow administration mifepristone 200 mg effective acceptable induce abortion compare misoprostol take sublingually ( tongue ) . Women present voluntary termination intrauterine pregnancy gestational age &lt; 63 day offer option participate study .</brief_summary>
	<brief_title>Study 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone Medical Abortion 63 Days Last Menstrual Period ( LMP )</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Gestational age less equal 63 day General good health include absence condition contraindicate use mifepristone misoprostol pregnancy termination ; Willing provide address and/or telephone number purpose followup . Confirmed suspect ectopic pregnancy undiagnosed adnexal mass IUD place Chronic renal failure Concurrent longterm corticosteroid therapy History allergy mifepristone , misoprostol prostaglandin Hemorrhagic disorder concurrent anticoagulant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Medical Abortion</keyword>
	<keyword>Mifepristone</keyword>
	<keyword>Misoprostol</keyword>
	<keyword>Sublingual administration</keyword>
	<keyword>Buccal administration</keyword>
</DOC>